Synergism of arsenic trioxide and MG132 in Raji cells attained by targeting BNIP3, autophagy, and mitochondria with low doses of valproic acid and vincristine-Reference-Cited by-同舟云学术

Synergism of arsenic trioxide and MG132 in Raji cells attained by targeting BNIP3, autophagy, and mitochondria with low doses of valproic acid and vincristine

Published:2014-12 Issue:18 Volume:50 Page:3243-3261
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Cavaliere Victoria,Lombardo Tomás,Costantino Susana N.,Kornblihtt Laura,Alvarez Elida M.,Blanco Guillermo A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference58 articles.

1. Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia;Hu;Proc Natl Acad Sci U S A,2009

2. Biological responses to arsenic compounds;Platanias;J Biol Chem,2009

3. Arsenic trioxide – An old drug rediscovered;Emadi;Blood Rev,2010

4. PML/RARalpha fusion protein mediates the unique sensitivity to arsenic cytotoxicity in acute promyelocytic leukemia cells: Mechanisms involve the impairment of cAMP signaling and the aberrant regulation of NADPH oxidase;Li;J Cell Physiol,2008

5. PML targeting eradicates quiescent leukaemia-initiating cells;Ito;Nature,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic plasticity in blast crisis-chronic myeloid leukaemia cells under hypoxia reduces the cytotoxic potency of drugs targeting mitochondria;Discover Oncology;2022-07-08

2. Protective effect of mitophagy against aluminum-induced MC3T3-E1 cells dysfunction;Chemosphere;2021-11

3. A drug potency signature links progression of chronic lymphocytic leukemia to mitochondria-related stress responses and metabolic reprogramming under hypoxia;Toxicology and Applied Pharmacology;2020-07

4. HDAC3 Silencing Enhances Acute B Lymphoblastic Leukaemia Cells Sensitivity to MG-132 by Inhibiting the JAK/Signal Transducer and Activator of Transcription 3 Signaling Pathway;Chemotherapy;2020

5. Inhibition of human constitutive 20S proteasome and 20S immunoproteasome with novel N ‐terminally modified peptide aldehydes and their antitumor activity;Peptide Science;2018-10-23